PAMP
IMNM icon

Polar Asset Management Partners’s Immunome IMNM Stock Holding History

Polar Asset Management Partners’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,800
Closed -$319K – 732
2024
Q3 		$319K Hold
21,800
– – 0.01% 476
2024
Q2 		$264K Buy
21,800
+4,000
+22% +$62.6K 0.01% 448
2024
Q1 		$439K Buy
+17,800
New +$361K 0.01% 471

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Asset Management Partners's IMNM Position: Q4 2024 in Review

Polar Asset Management Partners sold out of Immunome (IMNM) in Q4 2024, closing a stake of 21,800 shares — an estimated $319K sold.

Polar Asset Management Partners first reported a position in IMNM in Q1 2024 and held it in 3 quarters. The position peaked at $439K in Q1 2024. 120 funds tracked by Wall St. Rank hold IMNM as of Q4 2024.

  • Polar Asset Management Partners reported no remaining Immunome position as of Q4 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 21,800 Immunome shares in Q4 2024, an estimated $319K.
  • Polar Asset Management Partners first reported a position in Immunome in Q1 2024 and held it in 3 quarters.
  • Polar Asset Management Partners's Immunome position peaked at $439K in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Immunome as of Q4 2024.

Based on Polar Asset Management Partners's 13F filing for Q4 2024, filed 14 Feb 2025.